Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine?

Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine?

Last week, The U.S. government announced a deal with Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) to buy 100 million doses of the two partners' lead coronavirus vaccine candidate for $1.95 billion. Will Moderna be able to get away with such a higher price?